DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Lower urinary tract infection

Essential points for quick revision.

!
Possible pyelonephritis or urosepsis

Fever, rigors, flank pain, vomiting, hypotension, confusion or pregnancy with systemic illness is not an uncomplicated lower urinary infection.

Action: Use ABCDE, check glucose and lactate when indicated, obtain urine and blood cultures without delaying treatment, start the appropriate upper-tract or sepsis regimen and investigate urgently for obstruction.

Synopsis

Diagnose lower urinary tract infection without overcalling colonisation, identify upper-tract or septic disease and prescribe short, safe, susceptibility-aware treatment for distinct adult groups.

  • Lower urinary tract infection causes dysuria, frequency, urgency and suprapubic discomfort without fever, flank pain or systemic illness.
  • In women under 65, a symptom-led diagnostic approach is useful; vaginal discharge or irritation makes urinary infection less likely.
  • Culture urine before treatment in pregnancy and men, and when recurrent, resistant-risk, atypical, severe or failing to improve.

Key red flags

Fever, rigors, flank pain or costovertebral-angle tenderness suggests upper urinary tract infection.

Upper-tract boundary

Fever, rigors, loin pain, vomiting or costovertebral-angle tenderness should be managed as possible pyelonephritis rather than uncomplicated cystitis.

Investigation priorities

01
Structured symptom assessmentFirst step

Estimate lower UTI probability and identify upper-tract, genital or systemic features.

Management branches

WOMANTreat uncomplicated lower infection

A non-pregnant woman has a convincing lower urinary syndrome without systemic, flank or vaginal features.

  1. Assess symptom combination, previous cultures, resistance risk, renal function and immediate allergy and give self-care and safety-net advice.
  2. Use nitrofurantoin 100 mg modified-release twice daily for three days when eGFR is at least 45 mL/minute, or trimethoprim 200 mg twice daily for three days when resistance risk is low.

Key medicines

Nitrofurantoin modified releaseGive 100 mg orally twice daily for three days in non-pregnant women or seven days in men when prostate involvement is not suspected.
TrimethoprimGive 200 mg orally twice daily for three days in non-pregnant women or seven days in men when resistance risk is low.
Open full textbook Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom